Come up with a name for your new list and we'll add to it:
Alnylam Pharmaceuticals raised a round of funding on August 09, 2007. Investors include
Roche Venture Fund.
Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company believes that are many new therapeutic frontiers fo…